Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |